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Upon sensing of peptide pheromone, Enterococcus faecalis efficiently transfers plasmid pCF10 through a type
IV secretion (T4S) system to recipient cells. The PcfF accessory factor and PcfG relaxase initiate transfer by
catalyzing strand-specific nicking at the pCF10 origin of transfer sequence (oriT). Here, we present evidence
that PcfF and PcfG spatially coordinate docking of the pCF10 transfer intermediate with PcfC, a membrane-
bound putative ATPase related to the coupling proteins of gram-negative T4S machines. PcfC and PcfG
fractionated with the membrane and PcfF with the cytoplasm, yet all three proteins formed several punctate
foci at the peripheries of pheromone-induced cells as monitored by immunofluorescence microscopy. A PcfC
Walker A nucleoside triphosphate (NTP) binding site mutant (K156T) fractionated with the E. faecalis
membrane and also formed foci, whereas PcfC deleted of its N-terminal putative transmembrane domain
(PcfCN103) distributed uniformly throughout the cytoplasm. Native PcfC and mutant proteins PcfCK156T
and PcfCN103 bound pCF10 but not pcfG or oriT mutant plasmids as shown by transfer DNA immuno-
precipitation, indicating that PcfC binds only the processed form of pCF10 in vivo. Finally, purified PcfCN103
bound DNA substrates and interacted with purified PcfF and PcfG in vitro. Our findings support a model in
which (i) PcfF recruits PcfG to oriT to catalyze T-strand nicking, (ii) PcfF and PcfG spatially position the
relaxosome at the cell membrane to stimulate substrate docking with PcfC, and (iii) PcfC initiates substrate
transfer through the pCF10 T4S channel by an NTP-dependent mechanism.
The type IV secretion (T4S) systems are ancestrally related
to bacterial conjugation machines and are used by many spe-
cies of gram-negative and gram-positive bacteria as well as the
thermophilic archaeon Sulfolobus (19, 31, 32, 61). Most T4S
systems translocate DNA or protein substrates directly to tar-
get cells by a cell contact-dependent process, and some alter-
natively translocate substrates to or from the milieu (5, 6, 20).
Many systems translocate DNA substrates within or between
bacterial species, although a large number of systems have
been adapted by pathogenic species to deliver DNA or protein
substrates to fungal, plant, or human cells (7, 17, 53). The T4S
systems are composed of an envelope-spanning secretion chan-
nel and a surface structure such as a pilus for gram-negative
bacteria or a protein adhesin for gram-positive bacteria to
mediate attachment to target cells (1, 20, 32). These general
properties—a wide phylogenetic distribution, functional versa-
tility, and structural diversity—make T4S systems excellent
subjects for mechanistic studies exploring the evolution of bi-
ological complexity. At this time, however, detailed structure-
function comparisons are not possible due to the paucity of in-
formation available for systems other than a few gram-negative
models, e.g., the conjugation systems encoded by F, RP4, and
R388 plasmids and the A. tumefaciens VirB/D4 T4S system.
Here, we initiated studies of the pheromone-inducible con-
jugation system of the Enterococcus faecalis plasmid pCF10
(25). This 67.6-kb plasmid is a member of the family of sex
pheromone plasmids found to date only in the enterococci but
with the capacity to mobilize transfer of oriT-containing plas-
mids to Lactococcus lactis and Streptococcus agalactiae (64).
pCF10 carries the tetracycline resistance conjugative transpo-
son Tn925 (22) and codes for pheromone sensing and response
functions, conjugation functions, and a surface adhesin termed
aggregation substance (AS) which is important both for con-
jugation and virulence (38, 68, 69). In addition to its medical
importance as a reservoir for antibiotic resistance and other
virulence traits, the pCF10 transfer system is an attractive
model gram-positive T4S system for mechanistic analysis be-
cause T4S machine assembly and function are tightly con-
trolled at the transcriptional level, many features of phero-
mone-inducible regulation are known, and very high plasmid
transfer rates are achieved soon after induction (25, 38).
Bacterial conjugation can be viewed as three biochemical
reactions coupled in time and probably also in space. One or
more processing factors termed the DNA transfer and repli-
cation (Dtr) proteins initiate transfer by assembling as a rel-
axosome at the origin of transfer sequence (oriT) to catalyze
cleavage of the DNA strand (T strand) destined for transfer
(33). For pCF10, the PcfG relaxase and the accessory factor
PcfF function together to cleave DNA at the nic site within an
IncP-type oriT sequence (18, 64). Next, by a mechanism that is
poorly understood, the relaxosome or the processed transfer
intermediate interacts with a substrate receptor, also termed
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the type IV coupling protein (T4CP) (3). These membrane
proteins are components of all conjugation systems character-
ized to date and are related in sequence and overall structure
to the ATP-dependent DNA translocases FtsK and SpoIIIE
(27, 30). For pCF10, the putative T4CP is PcfC, whose se-
quence features include an N-terminal putative transmem-
brane (TM) domain, conserved Walker A and B nucleoside
triphosphate (NTP) binding motifs, and other motifs common
to this protein family (60; this study). In a final reaction, the
T4CP delivers the DNA substrate to a cognate T4S transport
apparatus for substrate transfer across the bacterial cell enve-
lope (16, 19, 61). The mating pair formation (Mpf) proteins are
responsible for target cell attachment and formation of tight
mating junctions and a membrane-spanning channel between
donor and recipient cells. In the case of pCF10, a 15-kb
region situated between prgB (codes for AS) and pcfC is pre-
dicted encode the translocation channel (18).
The DNA processing reactions of several gram-positive con-
jugative plasmids have been characterized in detail (14, 15, 18,
46, 63, 64). By contrast, structure-function studies of the cog-
nate mating pair formation and substrate transfer mechanisms
are still in their infancy, although an interaction network for
putative Mpf subunits of the S. agalactiae pIP501-encoded T4S
system recently was described (1). In this study, we have ex-
amined the question of how pCF10 substrate processing is
coupled to translocation at the cell membrane. Our cytological
and biochemical findings indicate that the PcfF and PcfG pro-
cessing factors not only catalyze the oriT nicking reaction but
also spatially position the relaxosome at several sites on the
membrane, most probably in proximity to the PcfC substrate
receptor. PcfF and PcfG deliver the processed form of pCF10
to PcfC, a substrate receptor for the pCF10 transfer system,
and in turn PcfC energizes substrate transfer through the
pCF10-encoded mating channel.
MATERIALS AND METHODS
Bacterial strains and growth conditions. Bacterial strains, plasmids, and oli-
gonucleotides are listed in Table 1. Escherichia coli DH5 (Gibco-BRL) and
EC1000, a strain that produces the pWV01 RepA protein (48), were used as
hosts for plasmid constructions. E. coli BL21(DE3) (Novagen) was used for
protein production. E. coli strains were cultured in Luria broth (LB) or brain
heart infusion broth (BHI) (Difco Laboratories) and grown at 37°C with shaking.
E. faecalis strains were cultured in BHI and grown at 37°C without shaking.
Antibiotics were added at the following final concentrations: for E. faecalis,
erythromycin at 100 g ml1 for plasmid markers and 10 g ml1 for chromo-
somal markers, fusidic acid at 25 g ml1 rifampin at 200 g ml1, chloram-
phenicol at 10 g ml1, spectinomycin at 1,000 g ml1 for plasmid markers and
250 g ml1 for chromosomal markers, streptomycin at 1,000 g ml1, at tetracy-
cline at 10 g ml1; for E. coli, carbenicillin at 50 g ml1, chloramphenicol at 20
g ml1, erythromycin at 100 g ml1, kanamycin at 50 g ml1, and spectinomycin
at 50 g ml1. All antibiotics were obtained from Sigma Chemical Co.
Plasmid constructions. Plasmid pCY32 was constructed as follows to delete
pcfC from pCF10. An 825-bp region immediately 5 of pcfC (upstream fragment)
was amplified with the primer pair pcfC-1/pcfC-2. A 945-bp region immediately
3 of pcfC (downstream fragment) was amplified with the primer pair pcfC-3/
pcfC-4. The two fragments were cloned sequentially into pCJK47 (Table 1) to
create pCY32 with the primer-added NcoI/SmaI (upstream fragment) and SmaI/
XbaI (downstream fragment) restriction sites. pCY32 was used to delete pcfC
from pCF10 by marker exchange as described previously (42).
Plasmid pCY24 expressing pcfC from the nisin-inducible promoter Pnis was
constructed by PCR amplification of pcfC with the primer pair BspHI-pcfC and
pcfC-R-XhoI (Table 1), digestion of the PCR product with BspHI and XhoI, and
introduction into NcoI/XhoI-digested pMSP3545 (Table 1). Plasmid pCY25 ex-
pressing pcfC from the constitutive promoter P23 from Lactococcus lactis was
constructed as follows. Plasmid pCIp23 carries promoter P23 from pDL278p23,
introduced as a 0.2-kb EcoRI/BamHI restriction fragment into similarly digested
pCI372. Plasmid pCY25, expressing the pcfC gene from promoter P23, was
constructed by PCR amplification of pcfC from pCF10 with primer pairs BsaI-
B-pcfC and pcfC-PstI, digestion of the PCR product with BsaI and PstI, and
introduction of the resulting fragment into BamHI/PstI-digested pCIp23. Plas-
mid pCY31 expressing pcfCN103 (lacks codons 1 to 103) from promoter P23
was constructed by PCR amplification of pcfCN103 with primer pair RBS-C (a
sequence containing an optimal ribosomal binding site was added to the primer)
and N103R and introduction of the PCR fragment into pGEM-T Easy. The
pcfCN103 allele, recovered as an SphI fragment, was introduced into similarly
digested pDL278p23. The orientation of pcfCN103 relative to P23 was verified
by restriction enzyme analysis.
Plasmid pCY26 expressing GST-pcfCN103 was constructed by amplification
of pcfC starting at codon 103 with primers GST-PcfC-103-F/GST-PcfC-R,
digestion with BamHI and EcoRI, and introduction into similarly digested
pGEX2T. Plasmid pCY27 expressing his6-pcfCN103 was constructed by ampli-
fication of pcfC starting at codon 103 with primers pcfCN103-F and pcfC-R-
XhoI, digestion with NdeI and XhoI, and introduction into similarly digested
pAP1. PcfC derivatives with Walker A mutations were constructed as follows.
The invariant Lys156 within the Walker A motif of PcfC was mutated by
QuikChange (Stratagene) site-directed mutagenesis according the manufactur-
er’s instructions. Plasmids pCY25, pCY26, and pCY27 served as templates for
PCR amplification with the Pfu Turbo polymerase using complementary oligo-
nucleotides pcfC-K/T-5 and pcfC-K/T-3 to construct a Lys156Thr (K156T) sub-
stitution. Plasmids pCY28, pCY29, and pCY30 were sequenced across the entire
pcfC gene to confirm introduction of the K156T mutation and lack of undesired
mutations.
Plasmid pCY34 expressing Ptac-GST-pcfF was constructed by PCR amplifica-
tion of pcfF with primer pair GSTF5 (BamHI and NdeI sites added to the
primer) and GSTF3 (XhoI site added to the primer), and the BamHI-XhoI-
digested product was cloned into similarly digested pGEX6p-1.
Conjugation assays. E. faecalis donor and recipient cultures grown overnight
were diluted 1:10 in fresh BHI and incubated at 37°C for 1 h. Donor and
recipient cells were mixed at a ratio of 1:10 and mated for 1 h at 37°C. Serial
dilutions of the mating mixtures were plated on selective BHI agar plates to
obtain CFU of transconjugants and donors. Plasmid transfer was expressed as
transconjugants per donor, and experiments were carried out in triplicate (18).
Cell fractionation and protein detection. Exponential-phase cultures (10 ml)
of E. faecalis strains carrying pCF10 or various pCF10 mutants were induced with
20 ng/ml of peptide cCF10 for 1.5 h. Exponential-phase E. faecalis strains were
incubated with 20 ng/ml of nisin (Sigma) for 2 h to induce expression from the
nisin-inducible promoter Pnis (37). Equivalent numbers of cells were pelleted by
centrifugation at 5,000  g for 10 min at 4°C and washed once with cold 1
physiologically buffered saline (PBS). Cells were frozen at 20°C overnight,
thawed, and treated with 200 l of lysozyme solution (10 mM Tris-HCl [pH 8.0],
50 mM NaCl, 1 mM EDTA, 20% sucrose, 15 mg/ml lysozyme, 10 g/ml mu-
tanolysin) at 37°C for 20 min. The protoplasts were resuspended in 1 ml of lysis
buffer (20 mM Tris-HCl [pH 8.0], 150 mM NaCl, 1 mM EDTA, 1 protease
inhibitor cocktail [Roche]) and lysed with sonication (Branson 250 microtip
sonicator). Unlysed cells were removed by centrifugation twice at 15,700  g for
30 min. The soluble lysates were subjected to ultracentrifugation at 165,000  g
for 2 h at 4°C. The supernatant contained the cytoplasmic fraction. The pellet
was resuspended by sonication in 1 ml of lysis buffer and was again subjected to
ultracentrifugation to remove residual cytoplasmic proteins. The pellet was re-
suspended in 1 ml of lysis buffer containing 1% Triton X-100. Cytoplasmic and
membrane fractions were applied on a per-cell equivalent basis onto sodium
dodecyl sulfate (SDS)-polyacrylamide gels and proteins of interest identified by
Western transfer and immunostaining, as previously described (9).
To monitor PcfC, -F, and -G protein production over time following phero-
mone induction, equivalent numbers of cells were harvested at the indicated time
points. After treatment with lysozyme solution (10 mM Tris-HCl [pH 8.0], 50
mM NaCl, 1 mM EDTA, 20% sucrose, 15 mg/ml lysozyme) at 37°C for 15 min,
protoplasts were lysed by boiling for 5 min in the lysis buffer (20 mM Tris-HCl
[pH 8.0], 150 mM NaCl, 1 mM EDTA, 1% Triton X-100) and analyzed by
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot analysis.
Protein purification. The proteins His6-PcfCN103, His6-PcfCN103K156T,
His6-PcfF, and PcfG-His6 were produced in strain BL21(DE3) carrying pCY27,
pCY30, pCY33, and pCY36, respectively. Bacteria were grown at 37°C in 100 ml
of LB medium supplemented with 50 g/ml kanamycin until the culture reached
an absorbance at 600 nm of 0.4. Isopropyl-	-D-thiogalactoside (Anatrace) was
added to a final concentration of 0.1 mM, cells were incubated at 30°C for 3 h,
and bacteria were pelleted by centrifugation at 6,000  g for 20 min. Cell pellets
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TABLE 1. Bacterial strains, plasmids, and oligonucleotides used in this study
Strain, plasmid, or oligonucleotide Relevant features or sequence (533) Source or reference
Strains
E. coli
DH5 F 
80dlacZ M15 (lacZYA-argF)U169 deoR recA1 endA1 hsdR17(rK
 mK
)
phoA supE44  thi-1 gyrA96 relA1
Gibco-BRL
BL21 (DE3) F ompT rB
 mB
 DE3 Novagen
EC1000 E. coli cloning host, provides RepA in trans 48
E. faecalis
CK104 OG1RFupp2 43
OG1ES Ermr Strr 64
OG1SSp Strr Spcr 26
Plasmids
Expression plasmids/vectors
pET-28a, b() Kanr, expression vector for His tagging Novagen
pAP1 Kanr, pET-28a() derivative 12
pGEX2T Crbr, expression vector for GST tagging Amersham
pGEX6P-1 Crbr, expression vector for GST tagging Amersham
pGEM-T Easy Crbr, TA cloning vector Promega
pCI372 Camr, shuttle vector 35
pDL278 Spcr, shuttle vector 70
pDL278p23 Spcr, pDL278 with L. lactis constitutive promoter P23 18
pCIp23 Camr, pCI372 with promoter P23 This study
pCJK47 Carries oriTpCF10, lacZ, and P-pheS* cassette 42
pMSP3535 Ermr, shuttle vector, inducible promoter Pnis 10
pMSP3545 Ermr, shuttle vector, inducible promoter Pnis 10
pCJK21 Ermr Spcr, shuttle vector, inducible promoter Pnis 43
pCF10 derivatives
pCF10 Pheromone-inducible conjugative plasmid 24
pCF10pcfC pCF10 deleted of pcfC This study
pCF10pcfF pCF10 deleted of pcfF 18
pCF10pcfG pCF10 with pcfG inactivated by Ll.ltrBORF-Kan insertion 64
pCF10oriT pCF10 deleted of oriT 64
pcfC expression plasmids
pCY24 pMSP3545 expressing Pnis-pcfC This study
pCY25 pCIp23 expressing P23-pcfC This study
pCY26 pGEX2T expressing Ptac-GST-pcfCN103 This study
pCY27 pAP1 expressing PT7-his6-pcfCN103 This study
pCY28 pCIp23 expressing P23-pcfCK156T This study
pCY29 pGEX2T expressing Ptac-GST-pcfCN103;K156T This study
pCY30 pAP1 expressing PT7-his6-pcfCN103;K156T This study
pCY31 pDL278p23 expressing P23-pcfCN103 This study
pCY32 pCJK47 with pcfC flanking sequences for construction of pCF10pcfC This study
pcfF expression plasmids
pCY33 pET-28b() expressing his6-pcfF 18
pCY34 pGEX6p-1 expressing GST-pcfF This study
pCY16 pDL278p23 expressing P23-pcfF 18
pcfG expression plasmids
pCY36 pET-28 b() expressing pcfG-his6 18
pCY19 pCJK21 expressing Pnis-pcfG 18
Oligonucleotides
pcfC-PstI AACTGCAGTTAAACGTGTGTTTCTTCTTTC
BsaI-B-pcfC CATGGTCTCGGATCCACGTGGGTAAAATTGATCAAAC
pcfC-K/T-5 ATCGCCATTCTAGGTGATTCTGGAGCGGCCACCACGTTAGCTTTT
pcfC-K/T-3 GGCCGCTCCAGAATCACCTAGAATGGCGATATTCTTATTTTTTTG
GST-pcfC-103-F CATGGTCTCGGATCCGCTCGTTTTGCTACACCTGC
GST-pcfC-R CATGGTCTCGAATTCTTAAACGTGTGTTTCTTCT
pcfCN103-F GCTCGTTTTCATATGGCTACACCTGC
pcfC-R-XhoI AACGCACGTCCTCGAGCTATTAGGCTAGAACGTGTGTTTC
pcfC-1 ATGGTACCGAGCAACCAGATGAAATAGC
Continued on following page
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were resuspended in 5 ml of buffer A (20 mM Tris-HCl [pH 8.0], 0.25 M NaCl,
1 EDTA-free protease inhibitor cocktail [Roche]) and sonicated to clarity. Cell
lysates were centrifuged at 15,000  g at 4°C for 20 min, and the supernatants
were subjected to an affinity column by using Talon (Co2) resin (Clontech)
equilibrated with buffer A. Bound proteins were incubated with Talon agarose at
4°C for 40 min, washed extensively with buffer A containing 20 mM imidazole,
and eluted with buffer A containing 200 mM imidazole.
The pooled fractions with high purity (90%) were further purified and
analyzed by gel filtration chromatography. For large sample preparations,
HiPrep 16/60 Sephacryl S200 HR columns were used with AKTA systems (GE
Healthcare). The columns were preequilibrated and run with buffer B (50 mM
Tris-HCl [pH 7.5], 1 mM dithiothreitol, 1 mM EDTA, 100 mM KCl, 5% glyc-
erol). For analytical gel filtration, a Tricorn high-performance column (Superdex
75 10/300 GL) was preequilibrated and run with buffer C (50 mM HEPES [pH
7.0], 100 mM NaCl, 2 mM MgCl2, 0.1 mM EDTA, 5% glycerol). The gel filtration
columns were calibrated by using aldolase, albumin, chymotrypsinogen A, and
RNase A (GE Healthcare) as standards.
Purified His6-PcfCN103 was sent to Cocalico Biologicals, Inc., (Reamstown,
PA) for antibody production in New Zealand White rabbits as previously de-
scribed (40). Similarly, purified His6-PcfF and PcfG-His6 were used to raise
antibodies in New Zealand White rabbits. Anti-PrgB antibodies were generated
previously (54).
PcfC, PcfF, and PcfG interaction assays. E. faecalis cells carrying pCF10 or
pCF10pcfC (20 ml) were induced with 20 ng/ml cCF10 pheromone peptide for
1.5 h, and cells were lysed by incubation at 4°C for 3 h in lysis buffer (20 mM
Tris-HCl [pH 8.0], 150 mM NaCl, 1 protease inhibitor cocktail, 1% Triton
X-100). The lysate was centrifuged at 4°C for 30 min, and the soluble material
was mixed with Talon resin alone or prebound with PcfG-His6 or His6-PcfF.
After incubation at 4°C for 3 h, the resins were washed extensively with buffer A
with 20 mM imidazole, and bound proteins were eluted with buffer A containing
250 mM imidazole. Eluted fractions were assayed for PcfC, PcfF, and PcfG
proteins by SDS-PAGE and immunostaining.
For glutathione S-transferase (GST) affinity chromatography, soluble fractions
of E. coli cells producing GST-PcfCN103, GST-PcfCN103K156T, or GST
alone were mixed with 50 l of glutathione-Sepharose beads for 1 h at room
temperature (RT). The Sepharose beads were pelleted by centrifugation at
500  g for 5 min and washed three times with 1 PBS. The beads were
resuspended in 500 l of binding buffer (20 mM Tris-HCl [pH 8.0], 0.1 M NaCl,
10 g bovine serum albumin). Purified PcfG-His6 or His6-PcfF (20 g) prepared
as described above was incubated with the glutathione-Sepharose beads alone or
prebound with GST or the GST-PcfC fusion proteins for 3 h at RT. The beads
were pelleted and washed five times with 1 ml of binding buffer containing 0.1%
Triton X-100. The extensively washed Sepharose beads were eluted twice with
elution buffer (10 mM glutathione, 0.1 M NaCl). The eluates were analyzed by
SDS-PAGE and immunostaining.
TNP-ATP binding assay. His6-PcfCN103 binding to the fluorescent ATP
analog TNP-ATP (Molecular Probes, Inc.) was determined by fluorescence emis-
sion with a F-2000 fluorescence spectrophotometer as previously described (36,
39, 62). Briefly, purified protein (2 M) obtained by sequential affinity and gel
filtration chromatographies was mixed with TNP-ATP (30 M) in Tris buffer (20
mM Tris-HCl [pH 8.0] and 50 mM NaCl in a 2-ml final volume). Following
incubation at RT for 10 s, the fluorescence emission spectrum between 470 and
650 nm was monitored upon excitation at 410 nm. For titration studies, TNP-
ATP was added sequentially to a fluorescence cuvette containing 1.5 M of
protein. The background intrinsic fluorescence of TNP-ATP in Tris buffer was
also measured and subtracted from fluorescence values obtained for the TNP-
ATP–protein mix.
TrIP assay. The transfer DNA immunoprecipitation (TrIP) assay was carried
out essentially as previously described (16) with modifications as follows. A 10-ml
culture of pheromone-induced cells in mid-exponential phase was pelleted and
resuspended in 2.5 ml 10 mM sodium phosphate buffer (pH 7.0). Formaldehyde
(FA) was added at a final concentration of 1%, and cells were incubated at 37°C
for 30 min. Glycine was added at a final concentration of 125 mM, and cells were
incubated at RT for 10 min and washed twice with 5 ml 1 PBS (pH 7.3). Cells
were converted to protoplasts by incubation in lysozyme solution as described
above, and protoplasts were lysed by incubation in immunoprecipitation buffer
(20 mM Tris-HCl [pH 8.0], 150 mM NaCl, 1 mM EDTA, 10 mg lysozyme, 1
protease inhibitor cocktail, 0.5% Triton X-100) for 20 min at 37°C and sonication
(Branson). The supernatant from subsequent centrifugation was incubated with
protein A-Sepharose CL4B (Pharmacia) (30-l bed volume) for 60 min at RT
and centrifuged at 5,000  g to remove protein A-Sepharose and nonspecifically
bound proteins. The supernatant was incubated overnight at 4°C with antibody
coupled to Protein A-Sepharose CL4B. The supernatant after this step corre-
sponds to the soluble fraction. The beads were washed twice with NP1 buffer
supplemented with 1% Triton X-100 and once with NP1 buffer supplemented
with 0.1% Triton X-100. To reverse the FA cross-links, immunoprecipitates were
resuspended in 150 ml of elution buffer (50 mM Tris-HCl [pH 8.0], 10 mM
EDTA, 1% SDS) and incubated overnight at 65°C. Supernatants were treated at
37°C for 2 h with 150 l of 60 mM Tris-HCl (pH 6.8), 5% glycerol, and
proteinase K (100 g/ml). The DNA was purified by phenol-chloroform extrac-
tion, precipitated with isopropanol, and washed with 70% ethanol. Immunopre-
cipitated DNA was resuspended in 25 ml of Tris-EDTA and subjected to PCR
amplification as described previously (16). For DNA detection, primers were
designed to amplify a 315-bp region of pCF10, a 175-bp region of pOriT, and a
485-bp region of the chromosome.
TABLE 1—Continued
Strain, plasmid, or oligonucleotide Relevant features or sequence (533) Source or reference
pcfC-2 CGCCCGGGACAGTTTCCTTCCTTT
pcfC-3 CGCCCGGGAAAGACGTGCGTT
pcfC-4 CGTCATTATCTAGAGCCAAAACAAGTTGG
TriP-ChromF TTACCAGTTTTGCAGTAGGG
TriP-ChromR TTCAGCCACTGTCATAGCTTG
pCF10oriTF3 GGTAAGTCGAAACGTCAAT
pCF10oriTR1 CTCCTTAGTTTCGACAATTG
pORIT-16-TriP-F TAAAGCCTGGGGTGCCTAATGAG
pORIT-16-TriP-R AATACGCAAACCGCCTCTC
TriP-pcfE-F ATGGACCAATTAACGGACG
TriP-pcfE-R CCCATCGCTACACTTTGACAT
TriP-pcfF-F GCGCGTCCTATTCAAAGAATAG
TriP-pcfF-R TGAAACTGATTGGCCAGACGG
GSTF5 CGGGATCCCATATGGAGAATAAACAAAAACTAAAA
GSTF3 CGGAATTCTTACGATTGATCCTTTCTCT
BspHI-pcfC ATGCTCATGACACAGACGTACAAAAAAGAACTG
RBS-C CGGGATCCTTAAAGGAGGTATTATCATATGGCTCGTTTTGCTACACC
TGCT
N103R ACATGCATGCCTGCAGCTCGAGTTAAACGTGTGTTTCTTCTT
pCF10 oriT-Sense AAATTCGCAACATGCTAGCATGTTGCTCCGCTTGCAAAAAGAAA
GCCG
pCF10 oriT-AntiSense GATCCGGCTTTCTTTTTGCAAGCGGAGCAACATGCTAGCATGTTGCG
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EMSA. Single-stranded DNA (ssDMA) and double-stranded DNA (dsDNA)
substrates were prepared as follows. The dsDNA substrate was constructed by
PCR amplification of a 186-bp fragment of pCF10 encompassing the oriT se-
quence by use of the primer pair pCF10oriTF3/pCF10oriTR1 and pCF10 as the
template and purification with the QIAquick PCR purification kit (Qiagen).
ssDNA substrates included pCF10-S, which contains the sense-strand sequence
of the minimal pCF10 oriT, and pCF10-AS, which contains the corresponding
antisense-strand sequence. Both oligonucleotides were synthesized and purified
by high-pressure liquid chromatography and PAGE. (Advanced Genetic Anal-
ysis Center and Microchemical Facility, University of Minnesota). ssDNA and
dsDNA substrates were labeled at the 3 ends with digoxigenin (DIG)-11-ddUTP
with the DIG gel shift kit (Roche) according to the manufacturer’s instructions.
A 39-mer DIG-labeled dsDNA oligonucleotide (supplied with the DIG gel
shift kit) served as a non-oriT substrate. Electrophoretic mobility shift assays
(EMSAs) were carried out in 20-l reaction mixtures composed of recombinant
proteins, DIG-labeled ssDNA or dsDNA, 0.2 g of poly[d(A-T)], 0.1 g of
poly-L-lysine, 1 reaction buffer (20 mM Tris HCl [pH 8.0], 0.1 M KCl, 10%
glycerol, 5 mM EDTA). The reaction mixtures were incubated at RT for 15 min,
loaded onto 8% polyacrylamide gels in 0.5 Tris-borate-EDTA buffer (pH 7.9),
and then subjected to electrophoresis at 100 V for 1.5 h and electrotransfer to a
nylon membrane (Roche) at 6 V for 2 h with the Genie electrophoretic blotter
(Idea Scientific). DIG-labeled DNA was visualized by an enzyme immunoassay
(DIG gel shift kit; Roche) following the manufacturer’s instructions. In compet-
itive EMSAs, a molar excess (10- or 100-fold) of cold competitor DNA was
added to the preformed probe-protein complexes (18).
Microscopy and image analysis. E. faecalis cells were grown to exponential
phase and induced with 20 ng/ml of cCF10 for 1.5 h or incubated for this period
without induction. Equivalent amount of cells (optical density at 600 nm  1.0)
were pelleted, washed three times with PBS, and resuspended in 300 l 1 PBS.
Cells were examined by immunofluorescence microscopy (IFM) as described
previously (2) with minor modifications. Briefly, 20 l of cells was spotted on
0.1% poly-L-lysine-treated microscopic slides, fixed overnight, and then treated
with lysozyme solution (10 mM Tris-HCl [pH 8.0], 50 mM NaCl, 1 mM EDTA,
20% sucrose, 15 mg/ml lysozyme) at RT for 30 min. Permeabilized cells were
analyzed with anti-PcfC, PcfF, -PcfG, and -PrgB primary antibodies and Alexa
Fluor 488 goat anti-rabbit immunoglobulin G secondary antibody (Molecular
Probes). Images of cells were acquired with an Olympus BX60 microscope
equipped with a 100 oil immersion phase-contrast objective as described pre-
viously (2).
RESULTS
pCF10 T4S gene arrangement and features. The putative tra
region of pCF10 encompasses up to 20 open reading frames
divisible into three functional groups (Fig. 1A). At the begin-
ning of the gene cluster are prg genes encoding surface proteins
PrgA (surface exclusion), PrgB or AS (cell-cell adhesion), and
PrgC (unknown function). Next, 13 prg/pcf genes are postu-
lated to encode the mating pair formation (Mpf) channel sub-
units; these genes code for (i) four homologs of gram-negative
T4S systems (with the A. tumefaciens VirB/D4 system (21) as a
reference, PrgH [29 kDa; polytopic VirB6-like channel sub-
unit], PrgJ [85 kDa; VirB4-like ATPase], PrgK [99 kDa; VirB1-
like cell wall hydrolase], and PcfC [70 kDa; VirD4-like
ATPase], (ii) other proteins with one or more putative -he-
lical TM domains (PrgD, PrgF, PrgI, PrgL), and (iii) predicted
cytoplasmic proteins (PrgE, PrG, PrgM, PcfA, and PcfB). As
expected, this region lacks the components of gram-negative
FIG. 1. pCF10 Tra region gene arrangement, protein functions, and similarities with the Agrobacterium tumefaciens VirB/D4 T4S system.
(A) The prg and pcf genes are grouped according to proposed functions and are color matched with genes encoding VirB/D4 protein homologs.
Core, genes whose products form a stable subassembly and are widely conserved among gram-negative T4S systems (20). The four related Prg/Pcf
and VirB proteins exhibit between 18 and 25% sequence identities. (B) PcfC resembles T4CPs of gram-negative T4S systems in its domain
architecture, with putative TM domains (TMDs) (gray); domains 1 and 2 (aqua); and conserved motifs (black), including Walker A and B NTP
binding motifs (60). The locations of the two PcfC mutations (N103, K156T) characterized in these studies are shown.
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systems thought to bridge inner and outer membrane machine
subassemblies (e.g., A. tumefaciens VirB8 and VirB10 energy
sensor), associate with the outer membrane (VirB7 lipoprotein
and VirB9), or elaborate the conjugative pilus (VirB2 and
VirB5). This region encodes a VirB4-like putative ATPase,
characteristic of all T4S systems identified to date, and does
not encode a VirB11 homolog, a third ATPase subunit of most
but not all T4S systems (61). At the distal end of the tra region
are the DNA transfer and replication (Dtr) genes whose prod-
ucts assemble as the catalytically active relaxosome at oriT.
These include PcfF and PcfG relaxase, both essential for pro-
cessing, and PcfD and PcfE, the production of which enhances
plasmid transfer frequencies by approximately 10- and 60-fold,
respectively (18).
Overall, the putative substrate receptor PcfC shares limited
sequence similarities with the well-characterized gram-nega-
tive T4CPs, e.g., A. tumefaciens VirD4At, RP4 TraGRP4, R388
TrwB388 (the subscript designates species or plasmid origin)
(Fig. 1B). However, PcfC possesses all conserved domains and
motifs previously identified and shown to be functionally im-
portant for the gram-negative T4CPs. These include two N-
terminal TM domains flanking a predicted periplasmic loop,
Walker A and B NTP binding motifs, and three additional
motifs clustered in a larger region previously designated do-
main 2 (Fig. 1B) (60).
pcfC genetic complementation and PcfC, PcfF, and PcfG
protein accumulation. We assessed the effect of a pcfC mu-
tation on pCF10 plasmid transfer. Upon pheromone induction,
the pcfC mutant strain accumulated wild-type (WT) levels of
PcfF and PcfG, indicating that the pcfC is nonpolar on ex-
pression of downstream genes (Fig. 2A). This strain failed to
transfer the mutant plasmid even in overnight matings on a
solid agar surface (Table 2). For genetic complementation
tests, WT pcfC was expressed from the nisin-inducible pro-
moter Pnis on plasmid pSM3545 or from the constitutive pro-
moter P23 on pCIp23. Interestingly, PcfC accumulated at high
levels when synthesized from the P23 promoter (Fig. 2A) but at
a level detectable only by concentration of cellular fractions
when synthesized from Pnis (see Fig. 3C). Yet, pcfC expression
from both promoters on plasmid pCY25 (P23-pcfC) or pCY24
(Pnis-pcfC) restored plasmid transfer to near-WT levels (Table
2), which indicates that PcfC is not rate limiting for plasmid
transfer when synthesized at low levels.
We constructed two PcfC mutants for further study, one
with Thr substituted for the invariant Lys residue in the Walker
A motif (K156T) and a second deleted of the N-terminal
putative membrane-spanning domain (N103) (Fig. 1B). The
mutant proteins accumulated at detectable levels (see below),
but neither supported pCF10pcfC transfer when synthesized
from pCY28 (P23-pcfCK156T) or pCY31 (P23-pcfCN103)
(Table 2), showing that both of these PcfC motifs are essential
for pCF10 transfer. Merodiploid strains cosynthesizing native
PcfC from pCF10 and the mutant proteins from pCY28 or
pCY31 transferred pCF10 at slightly reduced frequencies com-
pared to the corresponding vector-only isogenic strains (Table
2), consistent with the idea that PcfC functions as a homo- or
heteromultimer.
We also assayed for effects of pcfC, pcfF, and pcfG
mutations and a oriT mutation, made by deleting a
400-bp intergenic region between pcfE and pcfF (Fig. 1A),
on pheromone-inducible accumulation of PcfC, PcfF, and
PcfG. In induced cells, pcfC, pcfF, pcfG, and oriT mu-
tations generally had little or no effect on accumulation of
the other two Pcf proteins, with the interesting exception
that the pcfG mutant accumulated PcfC at very low levels
and the mutant expressing pcfG in trans accumulated PcfC
at high levels, suggestive of a possible stabilizing effect of
the relaxase on the T4CP (Fig. 2A).
FIG. 2. Synthesis of PcfC, PcfF, and PcfG in WT and mutant
strains. (A) Detection of Pcf proteins in mutant strains listed at top
without () or with synthesis of the complementing protein. Immu-
noblots were developed with antibodies to the proteins listed at left.
For comparisons, total protein extracts were loaded on a per-cell
equivalent basis. Proteins were synthesized from the constitutive pro-
moter P23 (PcfC and PcfF) or inducible promoter Pnis (PcfG). PcfG
synthesized from the weak promoter Pnis accumulated at levels detect-
able only upon enrichment of the membrane fraction (data not
shown). (B) Steady-state levels of PcfC, PcfF, and PcfG in strain
CK104(pCF10) (WT) were assessed over time following induction with
peptide pheromone cCF10. Left lanes, immunoreactive material from
the mutant strains shown.
TABLE 2. Transfer frequencies of WT pCF10 and
mutant derivatives
Plasmid(s)a Transfer frequency(transconjugants/donor)b
pCF10 ............................................................................... 1.7  101
pCF10pcfC..................................................................... 108
pCF10pcfC, pCY25 (P23-pcfC) ................................... 8.9  10
3
pCF10pcfC, pCY28 (P23-pcfCK156T) ........................ 10
8
pCF10pcfC, pCY31 (P23-pcfCN103) ....................... 10
8
pCF10pcfC, pCY24 (Pnis-pcfC)  nisin..................... 4.1  10
2
pCF10pcfC, pCY24 (Pnis-pcfC)  nisin..................... 2.6  10
6
pCF10, pCY28c (P23-pcfCK156T) .................................3.77  10
2
pCF10, pCY31c (P23-pcfCN103).................................8.11  10
2
a Donor strain, CK104; recipient strain, OG1SSP or OG1ES.
b Experiments were repeated three times in triplicate, and a representative
experimental result is reported.
c Isogenic strains carrying pCF10 and pCY25 (P23-pcfC) or the P23 vector
plasmid pCIp23 or pDL278p23 displayed WT pCF10 transfer frequencies (data
not shown).
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WT cells show a burst in plasmid transfer within 15 min
postinduction and a subsequent rapid increase to peak levels
within 2 h postinduction. Cells then enter a 2- to 3-h decline
phase marked by a reduction in plasmid transfer to preinduc-
tion levels (38). Correspondingly, PcfC, PcfF, and PcfG were
undetectable in uninduced cells and accumulated rapidly
within 15 to 30 min following induction, and then levels of all
three proteins remained high throughout the period of robust
plasmid transfer (Fig. 2B). However, levels of all three proteins
remained unchanged or decreased only slightly up to 10 h
postinduction, well after conjugation frequencies had declined
to preinduction levels (Fig. 2B) (38). Synthesis of PcfC, PcfF,
and PcfG therefore is essential for pCF10 transfer, but tar-
geted degradation of these transfer factors most probably does
not account for the significant reduction in plasmid transfer
over prolonged induction periods.
Subcellular localization and spatial positioning of PcfC,
PcfF, and PcfG. Cellular localization studies of T4S machines
and cognate substrates have proven valuable for understanding
the requirements for and dynamics of T4S-mediated substrate
recruitment and binding in vivo (2, 4). Initially, we determined
the subcellular localization of PcfC, PcfF, and PcfG by frac-
tionation of WT cells. As expected from its secondary structure
predicting a transmembrane topology, PcfC fractionated with
the membrane of pheromone-induced cells (Fig. 3A) and was
partially extracted from membranes with Triton X-100 and
other nonionic detergents but not with treatments including
salt, high pH, and bicarbonate (data not shown). PcfF and
PcfG do not carry predicted TM domains, and although PcfF
fractionated predominantly with the cytoplasmic material,
PcfG partitioned almost exclusively with the WT cell mem-
brane (Fig. 3A). Nonionic detergents, e.g., Triton X-100, 1 M
NaCl, and bicarbonate, released a substantial amount of PcfG
from the membrane (data not shown), suggestive of a periph-
eral membrane association. We further asked whether these
fractionation patterns were altered in the pcfC, pcfF, and
pcfG mutant backgrounds (Fig. 3A). PcfC partitioned with the
membrane fractions of both pcfF and pcfG mutant strains,
and PcfG similarly displayed WT fractionation behavior in the
pcfC mutant. Thus, both the putative T4CP and the relaxase
bind the membrane independently of each other.
Next, we analyzed the spatial organization of PcfC, PcfF,
and PcfG in pheromone-induced WT cells by IFM. Interest-
ingly, each protein formed ca. two to six punctate foci at the
peripheries of nearly all pheromone-induced WT cells (Fig.
3B). Moreover, each Pcf protein displayed WT distribution
patterns in mutant strains lacking one of the other Pcf proteins
(data not shown). In control experiments, no puncta were
visible at the peripheries of uninduced WT cells or induced
pcfC, pcfF, and pcfG mutant strains using antibodies against
the missing protein (data not shown). Because of the small size
of E. faecalis cells and the limits of resolution of IFM, we could
FIG. 3. Subcellular locations of PcfC, PcfF, and PcfG. (A) Pcf proteins in total cell (T), cytoplasm (C), and membrane (M) fractions of
cCF10-induced CK104(pCF10) (WT) or the mutant strains listed below each panel. Immunoblots were developed with antibodies to the proteins
listed at left. (B) Spatial distribution of PcfC, PcfF, PcfG, and PrgB proteins in pheromone-induced CK104(pCF10) cells. Proteins were detected
by IFM with antibodies to the proteins listed at the left. Corresponding cells were visualized by Nomarski microscopy (differential interference
contrast [DIC]). For each protein, representative fields with multiple cells or magnified individual cells are shown. (C) Corresponding subcellular
fractionation (using 20 concentrated fractions) and spatial analyses of PcfC and PcfCN103 and PcfCK156T mutant proteins synthesized from
the Pnis promoter in the pcfC mutant background.
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not confirm whether PcfC, PcfF, and PcfG colocalize at the
WT cell envelope. However, the results of in vitro protein-
protein interaction studies described below are consistent with
this proposal.
In further studies (Fig. 3C), we found that PcfCN103 de-
leted of the N-terminal putative TM domain partitioned al-
most exclusively with the cytoplasmic fraction, whereas the
PcfCK156T Walker A mutant displayed a WT fractionation
pattern. Correspondingly, PcfCN103 displayed uniform fluo-
rescence consistent with a cytoplasmic distribution, whereas
PcfCK156T formed WT foci at cell peripheries. The N-termi-
nal domain therefore mediates membrane binding and spatial
organization of PcfC, whereas the K156T mutation does not
appear to disrupt PcfC function through effects on membrane
binding.
Finally, we compared the spatial organization of PcfC, PcfF,
and PcfG with that of the AS PrgB. In early electron micros-
copy studies, it was shown that PrgB distributes uniformly at
the polar caps in most cells and as a narrow band approxi-
mately at the midcell in a fraction of other cells (54). Similarly,
when assessed by IFM, PrgG distributed uniformly at the polar
caps of most cells (Fig. 3B). We did not detect any punctate
foci reminiscent of those formed by PcfC, PcfF, and PcfG at
any time throughout a 10-h induction period, confirming that
T4S processing/transfer factors and the surface adhesin AS
differ distinctly in their spatial organization at the E. faecalis
envelope.
PcfC binds the processed form of pCF10 in vivo. The ob-
served similarities in PcfC, PcfF, and PcfG spatial patterns
suggested the possibility that PcfC binds the pCF10 transfer
intermediate in vivo. We tested for such an interaction by TrIP,
adapted from the chromatin immunoprecipitation assay (45),
for detection of substrate DNA-T4S channel subunit contacts
(3, 16). As shown in Fig. 4A, anti-PcfC antibodies precipitated
pCF10 DNA from extracts of FA-treated OG1RF(pCF10)
cells. In control experiments, the anti-PcfC antibodies did not
precipitate detectable amounts of chromosomal DNA from
extracts of FA-treated OG1RF(pCF10) cells or of plasmid or
chromosomal DNA from non-FA-treated OG1RF(pCF10)
cells or the FA-treated isogenic pcfC mutant (Fig. 4A). Fur-
ther, the anti-PcfC antibodies precipitated pOriT, a heterolo-
gous vector plasmid (pDL278) engineered to carry the pCF10
oriT sequence, but not a coresident pCF10oriT mutant plas-
mid. The antibodies also did not precipitate detectable levels
of the vector plasmid alone. We also assayed for, but did not
detect, precipitation of pcfG and oriT mutant plasmids from
extracts of FA-cross-linked strains (Fig. 4B). Thus, pCF10 pro-
cessing at oriT is required for detectable pCF10-PcfC binding,
indicating that PcfC binds exclusively to the pCF10 transfer
intermediate and not the closed covalent circular form of the
plasmid in vivo.
Finally, we tested for the capacity of the PcfCN103 and the
PcfCK156T Walker A mutant proteins to bind the pCF10
substrate. As shown in Fig. 4C, the anti-PcfC antibodies pre-
cipitated pCF10 but not chromosomal DNA from extracts of
FA-treated strains producing both mutant proteins. PcfC
therefore retains the ability to interact with the pCF10 sub-
strate in vivo independently of its N-terminal domain or an
intact Walker A motif.
PcfC binds ssDNA and dsDNA in vitro. The results of the
TrIP assays described above supplied evidence for binding of
the pCF10 transfer intermediate in vivo but did not establish
whether PcfC exhibits DNA sequence specificity or interacts
with the PcfF or PcfG processing factors. We attempted to
purify PcfC for further biochemical analyses but were unable
to obtain a soluble form of the full-length protein. However,
soluble His-tagged PcfCN103 was readily overproduced in E.
coli and purified to 95% homogeneity through sequential
steps of Co2 affinity and size exclusion chromatographies
(Fig. 5A). His6-PcfCN103 eluted from the size exclusion col-
umn as a narrow peak with an estimated molecular size of 60
kDa, the expected size of the monomer.
His6-PcfCN103 bound both dsDNA and ssDNA oriT-con-
FIG. 4. Detection of the PcfC-pCF10 interaction in vivo by use of
the TrIP assay. (A) Detection of pCF10 or chromosomal DNA in
immunoprecipitates recovered from FA-treated OG1RF(pCF10) or
the isogenic pcfC mutant cell extracts with anti-PcfC antibodies. PCR
amplification products were generated with primers against a pCF10
gene fragment (listed as plasmid [top] or p10 [right]) or a chromo-
somal fragment (Chrom [top] or chr [right]). MW, molecular mass
markers. PCR products were generated using supernatant (nonprec-
ipitated) (S) and immunoprecipitated (IP) material. (B) Detection of
PCR-amplified pCF10 or PoriT (plasmid [top] or p10 or pOriT [right])
or chromosomal (Chrom) DNA in immunoprecipitates recovered
from FA-treated OG1RF carrying the plasmids listed. (C) Detection
of PCR-amplified pCF10 (plasmid [top] or p10 [right]) or chromo-
somal (Chrom [top]) DNA in immunoprecipitates recovered from
FA-treated strains carrying pCF10pcfC and plasmids producing na-
tive PcfC, PcfCN103, or PcfCK156T from promoter Pnis.
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taining substrates, as shown by retardation of labeled DNA in
polyacrylamide gels (Fig. 5B). For both substrates, shifted
complexes increased in their molecular sizes as a function of
PcfC protein concentration, suggesting that PcfC monomers
bind DNA substrates noncooperatively at multiple sites or
multimerize or aggregate on DNA at high protein concentra-
tions. Complex formation was inhibited by unlabeled oriT-
containing and nonspecific competitor DNAs, indicating that
PcfC binds both dsDNA and ssDNA substrates without se-
quence specificity. In further experiments, additions of NTPs
to the reaction mixtures did not cause detectable changes in
DNA binding activities (data not shown). Finally, consistent
with results of the TrIP assay, His6-PcfCN103 carrying a
K156T mutation bound the DNA substrates (Fig. 5C). Some
differences in band shift patterns were detected between the
His6-PcfCN103 and K156T mutant protein (compare Fig. 5B
and C), possibly reflecting a slightly reduced affinity of the
K156T mutant for DNA or a propensity of the mutant protein
to aggregate in solution.
PcfCN103 binds TNP-ATP. We assayed for NTP binding
and hydrolysis activities of purified His6-PcfCN103, the
former with TNP-ATP, a fluorescent ATP analog that exhibits
enhanced fluorescence when bound to macromolecules (36,
39, 62). His6-PcfCN103 bound the fluorescent ATP analog, as
did the purified K156T mutant derivative albeit with a slightly
reduced affinity (Fig. 6A). By analysis of the binding curves,
His6-PcfCN103 bound TNP-ATP with a dissociation constant
(Kd) of 0.41 M and the K156T mutant with a Kd of 0.57 M
(Fig. 6B). Thus far, we have not been able to show that purified
His6-PcfCN103 hydrolyzes ATP or other NTPs in vitro.
PcfC interacts with the relaxosome components PcfF and
PcfG. In view of its nonspecific DNA binding activity, we pos-
tulated that PcfC recognizes the pCF10 substrate through in-
teractions with one or more relaxosome components. To test
this possibility, we purified His6-tagged forms of PcfF and PcfG
and assayed for interactions with full-length PcfC and
PcfCN103. Recombinant His6-PcfF from E. coli was soluble
and could be purified in large amounts by sequential affinity
and size exclusion chromatographies (Fig. 7A). The 14-kDa
protein eluted from the latter column as a single sharp peak
corresponding to a 60-kDa species, most probably a tet-
ramer. PcfG-His6 forms inclusion bodies when produced in
E. coli, but small amounts of soluble relaxase could be
purified to 90% homogeneity by Co2 affinity chromatog-
raphy (Fig. 7A).
His6-tagged PcfF and PcfG were prebound to Co
2 affinity
FIG. 5. His6-PcfCN103 purification and DNA binding in vitro. (A) Recombinant His6-PcfCN103 was purified by sequential affinity and gel
filtration chromatographies (see text). Upper panel, gel filtration elution profile showing protein in peak fractions corresponding to a molecular
size of 60 kDa. Lower panel, Coomassie blue-stained gel showing relative amounts of PcfC protein in the fractions listed. (B) DNA binding
activities of His6-PcfCN103 assessed by EMSA. Upper panel, EMSA using the 3-end-DIG-labeled 39-mer dsDNA fragment lacking the oriT
sequence (nonspecific DNA; 16 fmol). Lane 1, DNA probe only. Lanes 2 to 9, DNA probe plus His6-PcfCN103 at the following concentrations:
2, 83 nM; 3, 166 nM; 4, 332 nM; 5 to 9, 498 nM. Lanes 6 and 7, protein was preincubated with unlabeled oriT-containing competitor dsDNA at
concentrations 10-fold and 100-fold higher than that of the DIG-labeled substrate. Lanes 8 and 9, protein was preincubated with unlabeled
competitor nonspecific DNA at concentrations 10-fold and 100-fold higher than that of the DIG-labeled substrate. Lower panel, EMSA using the
3-end-DIG-labeled oriT-antisense ssDNA fragment (nonspecific DNA; 30 fmol). Reaction conditions were the same as described for the upper
panel. (C) EMSA using purified His6-PcfCN103K156T. Panels and reaction conditions are same as described for panel B.
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resin and then incubated with Triton X-100-treated cell lysates
of E. faecalis carrying pCF10 or pCF10pcfC. Following ex-
tensive washing, proteins were eluted with imidazole and an-
alyzed for the presence of the respective His-tagged protein
and PcfC. As shown in Fig. 7B, His6-tagged PcfF and PcfG
bound PcfC present in pCF10-carrying cell extracts. PcfC did
not bind the Co2 resin in the absence of these His6-tagged
proteins and, additionally, the His6-protein-bead complexes
did not bind cross-reactive material migrating at the size of
PcfC from pcfC cell extracts (Fig. 7B).
Next, we purified a GST-tagged form of PcfCN103 from E.
coli to assay for interactions with purified His6-tagged PcfF and
PcfG. GST-PcfCN103, or purified GST as a control, was
prebound to the affinity resin and incubated with one of the
His-tagged proteins. As shown in Fig. 7C, His6-PcfF and PcfG-
His6 coeluted with GST-PcfCN103, but not with GST, upon
incubation with glutathione. These data indicate that PcfC
interacts directly with each of the processing factors, PcfF and
PcfG.
Finally, we tested a prediction from previous studies (18)
that PcfF interacts directly with PcfG in the absence of a DNA
substrate. We constructed and purified GST-tagged PcfF and
assayed as described above for binding to PcfG-His6. As shown
in Fig. 7D, PcfG-His6 coeluted with GST-PcfF despite some
apparent proteolysis at or near the GST fusion junction, indic-
ative of a direct PcfF-PcfG interaction in vitro.
DISCUSSION
The pCF10 conjugation machine is an appealing gram-pos-
itive T4S system for detailed structure-function analysis due to
its medical importance and rapid induction kinetics (38) (Fig.
2B), permitting detailed investigations of T4S machine assem-
bly and function in space and time. Here, we used a combina-
tion of cytological and biochemical approaches to characterize
the interface of the pCF10 processing and translocation reac-
tions. The major findings from these investigations were as
follows: (i) PcfC is essential for pCF10 transfer and requires
both its N-terminal putative TM domain and an intact Walker
A motif for function; (ii) PcfC, PcfF, and PcfG form punctate
foci on the cell surface, whereas AS PrgB distributes uniformly
mainly around the polar caps; and (iii) PcfCN103 and the
K156T Walker A variant bind ATP, ss- and dsDNA, and the
PcfF and PcfG processing factors in vitro, and native PcfC and
the K156T mutant bind the processed form of pCF10 in vivo.
These findings are discussed below in the context of a model in
which the PcfF and PcfG processing factors and the PcfC
substrate receptor interact at a few sites at the E. faecalis
membrane to spatially coordinate early pCF10 processing and
translocation reactions.
The pCF10 processing reaction. Previously, it was shown
that purified PcfG catalyzes cleavage of an oriT ssDNA sub-
strate in vitro but requires PcfF to bind and nick the corre-
sponding dsDNA substrate (18). These findings suggested that
PcfF recruits PcfG to the plasmid’s oriT sequence, but they did
not identify the underlying recruitment mechanism. The ob-
servations that both PcfF and PcfG assemble as punctate foci
at the E. faecalis cell peripheries (Fig. 3) and that PcfF inter-
acts directly with PcfG in vitro (Fig. 7) suggest PcfF binds the
pCF10 oriT sequence and recruits PcfG through a direct pro-
tein-protein interaction to mediate relaxosome assembly at
discrete sites at the cell envelope. PcfC also forms punctate
foci (Fig. 3) and interacts in pairwise fashion with PcfF and
PcfG in vitro (Fig. 7), which initially led us to consider that
PcfC recruits one or both processing factors, or the assembled
relaxosome, to the cell membrane as a means of coupling the
processing and translocation reactions. However, this idea
proved incorrect because PcfC, PcfF, and PcfG display WT
spatial distribution patterns independently of each other or
pCF10 DNA (Fig. 3; Y. Chen, unpublished data). Further-
more, with the TrIP assay we gained evidence that PcfC inter-
acts exclusively with the processed form of pCF10 (Fig. 4). This
requirement for DNA processing suggests that PcfC does not
interact directly with the relaxosome but rather interacts with
the transfer intermediate, provisionally comprised of PcfG co-
valently bound to the 5 end of the T strand. Thus, we propose
a sequence of events in which PcfF and PcfG assemble the
FIG. 6. His6-PcfCN103 binds the fluorescent ATP analogue TNP-
ATP. (A) Fluorescence was measured with an excitation wavelength of
410 nM and scanning wavelengths from 470 to 650 nM. Spectra 1 to 4
were taken from the following samples: 1, Purified His-PcfCN103 (2
M) plus buffer; 2, TNP-ATP (30 M) plus buffer (duplicate results
are shown); 3, His-PcfCN103 (2 M) plus TNP-ATP (30 M) plus
ATP (10 mM) (duplicate results are shown); 4, His-PcfCN103 (2
M) plus TNP-ATP (30 M). The spectrum obtained for His-
PcfCN103K156T (2 M) plus TNP-ATP (30 M) closely matched
that for His-PcfCN103 (data not shown). (B) Binding of TNP-ATP to
WT and mutant PcfCN103. Concentration-dependent increases in
TNP-ATP fluorescence in the presence of PcfCN103 () and mutant
K156T () (1.5 mM each) indicate binding of this ATP analog to PcfC.
The apparent fluorescence (Fp  Ft) is represented in arbitrary units
after subtraction of intrinsic TNP-ATP fluorescence in buffer alone.
The solid lines show the best fit of the Hill model (Origin program),
giving Kds of 0.41 mM and 0.57 mM for WT PcfCN103 and mutant
K151T, respectively.
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relaxosome at the cell membrane independently of, but prob-
ably in spatial proximity to, PcfC. Upon generation of the
PcfG–T-strand complex, one or both processing factors then
deliver the transfer intermediate to the T4S receptor for trans-
location across the cell envelope.
Although several conjugative relaxases have been shown to
interact directly with cognate substrate receptors in vitro (1, 65,
68), there also is increasing evidence that conjugative process-
ing factors function as adaptors to spatially couple DNA sub-
strate-T4S receptor binding reactions in vivo. For example, in
the F plasmid transfer system, TraM stimulates TraI relaxase
activity and also functions as a substrate specificity determinant
by interacting with TraD via a C-terminal extension that is
unique to this T4S receptor (8, 23, 49). Similarly, in the R388
plasmid transfer system, TrwA stimulates the nicking reaction
through binding to oriT DNA and the TrwC relaxase (51, 52).
TrwA interacts with the TrwB T4S receptor and also stimulates its
ATPase activity, raising the intriguing possibility that substrate
binding mediated through TrwA might activate TrwB and the
cognate T4S system for translocation (65). In the A. tumefaciens
VirB/D4 T4S system, the ParA/MinD homolog VirC1 and its
interaction partner VirC2 stimulate VirD2-mediated cleavage at
T-DNA border sequences, and VirC1 also recruits VirD2 and the
T-DNA transfer intermediate to the polar-localized VirD4 recep-
tor (2). Recently, cytosolic proteins termed VirD2 binding pro-
teins also were shown to participate in polar recruitment of the
relaxase, although the VirD2 binding proteins do not appear to be
important for T-strand processing (34). Finally, MobB of plasmid
R1162 functions together with the MobC accessory factor and
MobA relaxase/primase to process IncQ plasmids. Reminiscent
of PcfF, MobB stimulates MobA nicking at oriT and also might
function as a spatial determinant for the relaxosome or the pro-
cessed substrate, as suggested by recent evidence that MobB is an
integral membrane protein, interacts with the MobA relaxase/
primase, and mediates MobA translocation to recipient cells
(55, 56).
FIG. 7. His6-PcfF purification, PcfG-His6 enrichment, and in vitro protein-protein interactions. (A) Recombinant His6-PcfF was purified by
sequential affinity and gel filtration chromatographies (see text). Upper panel, gel filtration elution profile showing protein in peak fractions
corresponding to a molecular size of 60 kDa. Middle panel, Coomassie blue-stained gel showing relative amounts of His6-PcfF protein in the
fractions listed. Bottom panel, PcfG-His6 enrichment by affinity chromatography. Lanes: 1, total extract from PcfG-His6-producing E. coli; 2, final
wash fraction; 3 and 4, first two fractions upon elution with 150 mM imidazole. (B) Binding of native PcfC to His-PcfF and PcfG-His6-CO
2 bead
complexes. His-tagged proteins prebound to the CO2 beads were mixed with E. faecalis cell extracts, and PcfC bound to the Pcf protein-bead
complexes was identified as described in the text. (C) Pull-down assays using purified His-tagged PcfF and PcfG and GST-tagged PcfCN103.
(D) Pull-down assays using purified PcfG-His6 and GST-PcfF.
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Biochemical properties of PcfC. PcfC is most closely related
to putative T4CPs associated with gram-positive conjugative
plasmids and transposons, but it also resembles the well-char-
acterized T4CPs of gram-negative systems (e.g., VirD4At,
TraGRP4, and TrwBR388) in molecular size, conservation of
Walker A and B and other motifs, and overall secondary struc-
ture predicting an N-terminal membrane-spanning domain
and a large cytosolic C-terminal domain (Fig. 1B) (60). Our in
vitro studies of PcfCN103, the only gram-positive T4CP pu-
rified and characterized to date, identified biochemical prop-
erties similar to those reported for gram-negative T4CP’s. As
was the case for other T4CPs (60, 62, 65, 66), we were unable
to purify sufficient amounts of soluble full-length PcfC for
biochemical analysis, whereas the N-terminally truncated pro-
tein was readily purified. PcfCN103 fractionated exclusively
as presumptive monomers by gel filtration (Fig. 5), also as
shown for other N-terminally truncated T4CPs (39, 60). Inter-
estingly, the soluble form of TrwBR388 crystallized as a hex-
amer (29, 30), yet there also is evidence that TrwBR388 and
other T4CPs exist as monomeric and higher-order multimeric
states in vivo, possibly in a dynamic equilibrium (60). Support-
ing this notion, TrwBR388 recently was reported to form hex-
amers upon incubation with DNA or with the accessory pro-
cessing factor TrwA (65). At this time, we have not detected
similar shifts in PcfCN103 oligomerization in the presence of
ss- or dsDNA substrates or the purified accessory factor PcfF
(Y. Chen and H.-J. Yeo, unpublished data).
Purified forms of N-terminally truncated PcfC and the
K156T mutant bound TNP-ATP with similar affinities, consis-
tent with previous findings for TrwBR388 and TraGRP4 (39).
Recently, truncated TrwBR388 was shown to hydrolyze ATP in
the presence of DNA oligonucleotides of a specific length and
the processing factor TrwA (65, 66). An Ala substitution for
Trp216 located in the internal channel of the TrwB hexamer
abolished ATPase activity, although the ATPase activity of a
K136T mutation corresponding to the PcfCK156T mutation
was not characterized (66). Presently, we also have not de-
tected PcfCN103 NTPase activity in the presence either of
different DNA substrates or of purified accessory factor PcfF.
Our observations that the full-length PcfCK156T mutant
displayed WT activities with respect to (i) membrane binding
and spatial organization (Fig. 3), (ii) pCF10 substrate binding
in vivo and nonspecific DNA binding in vitro (Fig. 4 and 5),
and (iii) interactions with purified PcfF and PcfG in vitro (Y.
Chen, unpublished findings) strongly indicate that the K156T
mutation disrupts a stage of the transfer pathway subsequent
to substrate processing and PcfC receptor docking. Similarly,
in A. tumefaciens, VirD4Walker A mutants show no defects in
spatial positioning or T-DNA substrate binding, and results of
TrIP studies further indicate that VirD4 functions together
with the VirB4 and VirB11 ATPases to energize T-DNA trans-
fer across the inner membrane (3). pCF10 encodes a VirB4
ATPase homolog (PrgJ), a feature of all T4S systems charac-
terized to date, and we recently determined that PcfC interacts
with PrgJ in vitro (Y. Chen, unpublished data) consistent with
a proposal that these two putative ATPases act together to
energize translocation. The pCF10 transfer system lacks a
VirB11 ATPase homolog, a feature also characteristic of most
or all gram-positive bacterial T4S systems. Most gram-negative
bacterial T4S systems possess VirB11 ATPases, although a few
notable exceptions exist, such as the F plasmid conjugation
system.
PcfCN103 bound nonspecifically and with similar affinities
to dsDNA and ssDNA substrates (Fig. 5). The purified, N-
terminally truncated T4CPs of the gram-negative systems sim-
ilarly bind DNA without sequence specificity but vary in pref-
erential binding to dsDNA (Helicobacter pylori HP0524) or
ssDNA (TrwBR388, TraGRP4, and TraDF) substrates (39, 50,
60, 62). In view of these nonspecific DNA binding properties,
T4CPs most likely recognize cognate DNA substrates through
a combination of interactions with the relaxase component of
the transfer intermediate and other processing factors func-
tioning as adaptors or spatial determinants. It is of interest that
among the gram-negative conjugation systems, relaxases and
other protein substrates carry C-terminal translocation signals
comprised of clusters of positively charged residues that are
necessary, albeit probably not sufficient, for substrate transfer
(20, 40, 55, 67). PcfF and PcfG lack such C-terminal charge
clusters, suggesting that other motifs confer substrate recogni-
tion in this gram-positive T4S system.
pCF10 T4S machine spatial organization. The spatial orga-
nization of bacterial secretion machines and other surface or-
ganelles has received considerable attention in recent years,
but to date there are only a few reports describing the spatial
distribution of T4S machines. Besides the polar-localized
VirB/D4 T4S system of A. tumefaciens (4, 41, 44, 47), there is
evidence that the Dot/Icm T4S machine assembles at the cell
poles of Legionella pneumophila (J. Vogel, personal communi-
cation), whereas the plasmid R27 T4S system assembles at five
or six places around the E. coli cell envelope (28). In gram-
negative bacteria, the secretion channel and attachment or-
ganelle, e.g., the conjugative pilus, are generally considered to
colocalize at the cell surface, with the latter playing a direct
role in formation of productive mating pairs. By contrast, in
the E. faecalis pCF10 system, we have shown that the AS
surface adhesin and T4S system components assemble differ-
ently at cell the surface (Fig. 4). Thus, while AS functions to
induce nonspecific cell clumping, it appears that only a subset
of these cell-cell contacts progress to form mating junctions.
Factors governing the spatial distribution of AS and the T4S
system components are unknown, but studies of other gram-
positive secretion systems have identified potential localizing
determinants, including membrane microdomains, cytoskeletal
filaments, and components of the cell wall synthesis machinery
(11, 13, 57). In Streptococcus pyogenes, for example, a single
microdomain termed Exportal is enriched in anionic lipids and
a high concentration of general secretory pathway translocons
and represents the primary site for protein secretion across the
cell envelope (58, 59).
By contrast, in rod-shaped Bacillus subtilis and Listeria
monocytogenes, the general secretory pathway translocons are
organized in spiral-like structures along the cell, also at sites
enriched in anionic lipids (11, 13). Presently, we are exploring
the basis for the spatial organization of the pCF10 T4S ma-
chine at the E. faecalis envelope, and we also are intrigued to
investigate whether this apparatus dynamically redistributes as
a function of cell growth, pheromone induction phase, or es-
tablishment of cell-cell contacts.
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